Risk of septic arthritis in patients with rheumatoid - The British ...

More documents

Recommendations

Info

Baseline characteristics ETA INF ADA Number of patients 4219 3467 4202 Mean age: Years (SD) 56 (12) 56 (12) 57 (12) Females: % 77 76 76 Median disease duration: Years (IQR) 12 (6-19) 12 (6-19) 10 (5-18) Disease activity: • Mean DAS28 score (SD) Range 1-9 • Mean HAQ (SD) Range 0-3 6.6 (1.0) 2.1 (0.6) 6.6 (1.0) 2.1 (0.6) 6.5 (1.0) 2.0 (0.6) Baseline prior orthopaedic surgery 26 24 21
Results Septic Arthritis within the BSRBR Cohort Pyears fup N Incident rate / 1000 pyears follow up All cases 202 DMARD cohort 9,094 18 1.9 All TNF cohort 36,230 184 5.1 Individual drug rates Etanercept 15,784 92 5.8 Infliximab 9,622 43 4.5 Adalimumab 10,733 49 4.6
Page 1 and 2: Risk of septic arthritis in patient
Page 3 and 4: Septic Arthritis • Septic arthrit
Page 5 and 6: Anti-TNF therapy and infection 5.0
Page 7 and 8: Aims • To establish the effect of
Page 9 and 10: BSR Biologics Register Control Coho
Page 11 and 12: Case validation • Physician confi
Page 13: Baseline characteristics DMARD Anti
Page 17 and 18: Pattern of cultured organisms Anti-
Page 19 and 20: Native joint infection • Approxim
Page 21: Acknowledgements • UK Consultant

Risk of septic arthritis in patients with rheumatoid - The British ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?